Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.

The Food and Drug Administration has approved a new antiretroviral treatment for HIV made by Johnson & Johnson, the agency said Friday.

Patients with HIV who immediately started antiretroviral therapy significantly reduced the risk of spreading the virus to an uninfected partner, compared with those who delayed therapy, according to results of a multinational study. The study also found that antiretroviral therapy reduced the risk of transmission by 96%.

Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

A nonprofit clinic that caters to New York’s gay, lesbian, bisexual and transgender communities and people living with HIV and AIDS has opened a new pharmacy.

Bristol-Myers Squibb has signed a definitive licensing pact with Oncolys BioPharma, a privately held Japanese biotech company, that will give it control of a promising new HIV treatment.

Pharmacy advocates are using every tool they can to spread the message that pharmacists bring a lot more than prescription services to the healthcare table. So how about a 341-ft. digital billboard looming above Times Square?

Walgreens is making a high-impact health statement to mark World AIDS Day that will be hard to ignore.

The Food and Drug Administration has approved a drug for treating excess fat development in...

Drug maker Boehringer Ingelheim and the Latino Commission on AIDS have launched a website targeted...

A new study looking at the role probiotics may play in increasing CD4 cell count...